Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Fresenius Kabi announced the Food and Drug Administration has approved Kabiven and Perikabiven in a 3-chamber bag. This is the only container of its kind currently available.
RELATED: FDA Approves New Parenteral Nutrition Therapy
Kabiven and Perikabiven are intravenous (IV) parenteral nutrition products that contain lipids (Intralipid 20%), dextrose, amino acids, and electrolytes indicated for patients who cannot digest, or absorb sufficient nutrition through the gastrointestinal tract. The 3-chamber design allows the delivery of the premixed solution that is shelf-stable until activated for patient use.
For more information call (888) 386-1300 or visit Fresenius-Kabi.us.
Related Content
